175 related articles for article (PubMed ID: 11855658)
1. Mechanism of action of Ca2+ sensitizers--update 2001.
Endoh M
Cardiovasc Drugs Ther; 2001 Sep; 15(5):397-403. PubMed ID: 11855658
[TBL] [Abstract][Full Text] [Related]
2. Cardiac Ca2+ signaling and Ca2+ sensitizers.
Endoh M
Circ J; 2008 Dec; 72(12):1915-25. PubMed ID: 18981594
[TBL] [Abstract][Full Text] [Related]
3. Troponin C-mediated calcium sensitization by levosimendan accelerates the proportional development of isometric tension.
Haikala H; Levijoki J; Lindén IB
J Mol Cell Cardiol; 1995 Oct; 27(10):2155-65. PubMed ID: 8576932
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of action of novel cardiotonic agents.
Endoh M
J Cardiovasc Pharmacol; 2002 Sep; 40(3):323-38. PubMed ID: 12198318
[TBL] [Abstract][Full Text] [Related]
5. Contribution of cAMP-phosphodiesterase inhibition and sensitization of the contractile proteins for calcium to the inotropic effect of pimobendan in the failing human myocardium.
Böhm M; Morano I; Pieske B; Rüegg JC; Wankerl M; Zimmermann R; Erdmann E
Circ Res; 1991 Mar; 68(3):689-701. PubMed ID: 1660359
[TBL] [Abstract][Full Text] [Related]
6. Levosimendan, a new inotropic and vasodilator agent.
Toller WG; Stranz C
Anesthesiology; 2006 Mar; 104(3):556-69. PubMed ID: 16508404
[TBL] [Abstract][Full Text] [Related]
7. Levosimendan, a new calcium-sensitizing inotrope for heart failure.
Ng TM
Pharmacotherapy; 2004 Oct; 24(10):1366-84. PubMed ID: 15628834
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology of SCH00013: a novel Ca2+ sensitizer.
Endoh M; Sugawara H; Mineshima M
Cardiovasc Drug Rev; 2001; 19(4):345-66. PubMed ID: 11830752
[TBL] [Abstract][Full Text] [Related]
9. Levosimendan in regional myocardial ischemia.
Pieske B
Cardiovasc Drugs Ther; 2002 Sep; 16(5):379-81. PubMed ID: 12656119
[No Abstract] [Full Text] [Related]
10. Two inotropes with different mechanisms of action: contractile, PDE-inhibitory and direct myofibrillar effects of levosimendan and enoximone.
Szilágyi S; Pollesello P; Levijoki J; Haikala H; Bak I; Tósaki A; Borbély A; Edes I; Papp Z
J Cardiovasc Pharmacol; 2005 Sep; 46(3):369-76. PubMed ID: 16116344
[TBL] [Abstract][Full Text] [Related]
11. Effects of Levosimendan, a cardiotonic agent targeted to troponin C, on cardiac function and on phosphorylation and Ca2+ sensitivity of cardiac myofibrils and sarcoplasmic reticulum in guinea pig heart.
Edes I; Kiss E; Kitada Y; Powers FM; Papp JG; Kranias EG; Solaro RJ
Circ Res; 1995 Jul; 77(1):107-13. PubMed ID: 7788868
[TBL] [Abstract][Full Text] [Related]
12. Troponin C-mediated calcium sensitization induced by levosimendan does not impair relaxation.
Haikala H; Nissinen E; Etemadzadeh E; Levijoki J; Lindén IB
J Cardiovasc Pharmacol; 1995 May; 25(5):794-801. PubMed ID: 7630157
[TBL] [Abstract][Full Text] [Related]
13. Calcium sensitization as new principle of inotropic therapy in end-stage heart failure?
Zimmermann N; Boknik P; Gams E; Herzig JW; Neumann J; Scholz H
Eur J Cardiothorac Surg; 1998 Jul; 14(1):70-5. PubMed ID: 9726618
[TBL] [Abstract][Full Text] [Related]
14. A Review on Role of the Calcium Sensitive Inotropic Agent, Levosimendan and Its Metabolites.
Asif M
Mini Rev Med Chem; 2018; 18(16):1354-1362. PubMed ID: 27594341
[TBL] [Abstract][Full Text] [Related]
15. Changes in intracellular Ca2+ mobilization and Ca2+ sensitization as mechanisms of action of physiological interventions and inotropic agents in intact myocardial cells.
Endoh M
Jpn Heart J; 1998 Jan; 39(1):1-44. PubMed ID: 9601480
[TBL] [Abstract][Full Text] [Related]
16. Effects of levosimendan on myocardial contractility and Ca2+ transients in aequorin-loaded right-ventricular papillary muscles and indo-1-loaded single ventricular cardiomyocytes of the rabbit.
Sato S; Talukder MA; Sugawara H; Sawada H; Endoh M
J Mol Cell Cardiol; 1998 Jun; 30(6):1115-28. PubMed ID: 9689586
[TBL] [Abstract][Full Text] [Related]
17. [Calcium sensitizers--a new group of drugs that increase myocardium contractility].
Laine M; Lehtonen L; Nieminen MS
Duodecim; 2000; 116(20):2181-3. PubMed ID: 12017622
[No Abstract] [Full Text] [Related]
18. The role of Ca++-sensitizers for the treatment of heart failure.
Lehmann A; Boldt J; Kirchner J
Curr Opin Crit Care; 2003 Oct; 9(5):337-44. PubMed ID: 14508145
[TBL] [Abstract][Full Text] [Related]
19. Effects of calcium sensitizers on intracellular calcium handling and myocardial energetics.
Hasenfuss G; Pieske B; Kretschmann B; Holubarsch C; Alpert NR; Just H
J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S45-51. PubMed ID: 8907130
[TBL] [Abstract][Full Text] [Related]
20. Positive inotropic effect of levosimendan is correlated to its stereoselective Ca2+-sensitizing effect but not to stereoselective phosphodiesterase inhibition.
Kaheinen P; Pollesello P; Hertelendi Z; Borbély A; Szilágyi S; Nissinen E; Haikala H; Papp Z
Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):74-8. PubMed ID: 16433895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
